Accessibility Menu
Picard Medical logo

Picard Medical(NYSEMKT) PMI

Market Cap$20.58MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2025)-96%
5 YearN/A
1 YearN/A
1 Month+100%
$8.40
-4.55%
-0.40Today
After hours$8.06-$0.34 (-4.05%)
Picard Medical last closing stock price
MetricPriceDate
Last closeUSD 8.802026-08-28
Picard Medical stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+174.14%USD 3.212026-08-21
1 month+100.25%USD 4.392026-07-22
3 month+19.32%USD 7.382026-05-29
Year to date-89.94%USD 87.502025-12-31
Since inception-96.17%USD 229.502025-08-29

Picard Medical Financials at a Glance

Market Cap

$20.58MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$6.30M

Net Income (TTM)

-$27.99M

EPS (TTM)

-$20.65

P/E Ratio

-0.43

Dividend

$0.00

Beta (Volatility)

0.99 (Low)

Price

$8.40

Volume

2,253,151.543

Open

$8.04

Previous Close

$8.46

Daily Range

$7.92 - $11.87

52-Week Range

$2.65 - $684.00

Estimated Earnings Date

Nov 13, 2026

PMI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Picard Medical

Picard Medical makes artificial hearts for people with severe heart failure. Its main product, the SynCardia Total Artificial Heart, replaces a failing human heart. This device helps patients survive until they can receive a heart transplant.

Gadgets That Keep Ticking: Products and Services

  • SynCardia Total Artificial Heart (TAH): Implantable device that fully replaces both heart ventricles and all four valves; 100% of 2025 revenue.
  • Freedom Driver: Portable external power source for the TAH, rented to patients; no rental revenue in 2025.
  • Training and Certification: Required education for transplant centers before first TAH use; bundled with product sales.

Growth Spurts and Global Hops

  • Acquired SynCardia in 2021, entering the artificial heart market.
  • Expanded sales to Europe and 27 countries by 2025.
  • Filed new patents in the U.S. and China for next-generation heart technology in 2025.
  • Completed IPO in September 2025, raising $17 million for expansion and R&D.

What Makes Picard Medical Stand Out

Picard Medical is the only company with a fully approved artificial heart for total heart replacement in the U.S. Its device is used when both sides of the heart fail, not just one. The company holds patents for future artificial heart systems and focuses on expanding into new markets.

Five Things You Need to Know

  • Revenue was $2.0 million in Q2 2025, up 207.1% from Q2 2024.
  • All 2025 revenue came from product sales; no rental income reported.
  • Gross loss was $127,000 in Q2 2025, improved from $382,000 in Q2 2024.
  • Net loss was $6.72 million in Q2 2025, up from $4.06 million in Q2 2024.

Bottom Line

Picard Medical focuses on life-saving heart devices and global expansion. The company faces financial challenges but holds a unique position in artificial heart technology.

AI Generated • Apr 16, 2026

Industry

Healthcare Equipment and Supplies

Employees

75

CEO

Richard Fang, PhD, MBA

Headquarters

Tucson, AZ 85713, US

PMI Financials

Key Financial Metrics (TTM)

Gross Margin

25.02%

Operating Margin

-240.84%

Net Income Margin

-444.30%

Return on Equity

-931.09%

Return on Capital

-118.91%

Return on Assets

-305.35%

Earnings Yield

-2.33%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$20.58MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

2.34M

Volume

2.25M

Avg. Volume

1.92M

Financials (TTM)

Gross Profit

$1.58M

Operating Income

-$15.17M

EBITDA

-$24.06M

Operating Cash Flow

-$16.04M

Capital Expenditure

-$26.00K

Free Cash Flow

-$16.07M

Cash & ST Invst.

$38.00K

Total Debt

$878.00K

Picard Medical Performance Analysis

Picard Medical annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 4,113,000N/A
20232023-12-31USD 5,043,00022.6%
20242024-12-31USD 4,391,000-12.9%
20252025-12-31USD 4,940,00012.5%
Picard Medical sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-44.3%
Q42025-12-31-15.0%
Q12026-03-3114.0%
Q22026-06-30156.9%
Picard Medical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -8.76N/A
20232023-12-31USD -243.892684.5%
20242024-12-31USD -16.41-93.3%
20252025-12-31USD -18.3211.6%
Picard Medical sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-90.0%
Q42025-12-3169.4%
Q12026-03-31-71.8%
Q22026-06-3039.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$2.95M

+38.6%

Gross Profit

$616.00K

+585.0%

Gross Margin

20.85%

N/A

Market Cap

$20.58MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$274.40K

N/A

Employees

75

N/A

Net Income

-$5.66M

+24.7%

EBITDA

-$4.50M

-7.8%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$38.00K

-90.7%

Total Debt

$878.00K

-96.1%

Accounts Receivable

$614.00K

-56.5%

Inventory

$5.97M

-14.7%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$878.00K

-96.0%

Return on Assets

-3.05%

N/A

Return on Invested Capital

-8.84%

N/A

Free Cash Flow

-$1.35M

+46.8%

Operating Cash Flow

-$1.35M

+46.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About PMI

What is the current price of Picard Medical?

Picard Medical is trading at $8.46 per share.

What is the 52-week range for Picard Medical?

Over the past 52 weeks, Picard Medical has traded between $2.65 and $684.00.

How much debt does Picard Medical have?

As of the most recent reporting period, Picard Medical reported total debt of $1.58M.

How much cash does Picard Medical have on hand?

Picard Medical reported $38.00K in cash and cash equivalents in its most recent financial results.

What is Picard Medical’s dividend yield?

Picard Medical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.